0
CLINICAL NOTES   |    
TREATMENT OF SEVERE WEIGHT LOSS WITH METHANDROSTENOLONE—A LESS VIRILIZING ANABOLIC AGENT
DUNCAN R. MACMASTER; KHOSROW ALAMIN
Am J Psychiatry 1963;120:179-180.
View Article Information
New Jersey State Hospital, Greystone Park, N. J.
text A A A
PDF of the full text article.
Abstract
Forty-seven mentally disturbed, severely underweight female patients, ranging in age from 15 to 86 years, were treated for an average of 45.55 days with the anabolic agent, methandrostenolone. All patients showed an increase in weight for a group average of 7.81 pounds. The most adequate dosage consisted of 5 mg. tablets administered b.i.d. One young adolescent patient, 15 years of age, developed a slight acne, some hirsutism and menorrhagia. Three patients (6.3%) became amenorrheic. Five patients (10.6%) had reduced menses. There were no changes in pulse or blood pressure. In this series there were no voice changes or jaundice. The gain in weight, improvement in feeling of well-being and increased appetite engendered an improved psychological attitude and a greater interest in daily activities.Abstract Teaser
Figures in this Article

    Your Session has timed out. Please sign back in to continue.
    Sign In Your Session has timed out. Please sign back in to continue.
    Sign In to Access Full Content
     
    Username
    Password
    Sign in via Athens (What is this?)
    Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
    Not a subscriber?

    Subscribe Now/Learn More

    PsychiatryOnline subscription options offer access to the DSM-IV-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

    +
    +
    +

    CME Activity

    There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
    Submit a Comments
    Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
    Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

    * = Required Field
    (if multiple authors, separate names by comma)
    Example: John Doe



    Related Content
    Articles
    Books
    Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 46.  >
    Topic Collections
    Psychiatric News
    PubMed Articles
    METHANDROSTENOLONE, AN ORAL ANABOLIC AGENT.
    Southern medical journal 1964 Aug